The TCR Therapy industry has emerged as a transformative segment within immuno-oncology, driven by its potential to treat a broad range of cancers resistant to conventional therapies. This rapidly evolving market reflects significant advancements in adoptive T-cell therapies and personalized medicine, highlighting dynamic market growth and expanding commercialization prospects.Market Size and...